US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5656211A
(en)
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US6217849B1
(en)
|
1993-09-29 |
2001-04-17 |
Bracco Research S.A. |
Liposome suspensions as blood pool imaging contrast agents
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
EP0759785B1
(en)
*
|
1995-02-24 |
2001-10-31 |
Bracco Research S.A. |
Liposome suspensions as blood pool imaging contrast agents
|
US5997898A
(en)
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
GB9519654D0
(en)
*
|
1995-09-27 |
1995-11-29 |
Nycomed Imaging As |
Stabilised phospholipid compositions
|
ATE345682T1
(de)
|
1996-05-01 |
2006-12-15 |
Imarx Pharmaceutical Corp |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
WO1998005364A2
(en)
*
|
1996-08-02 |
1998-02-12 |
Marsden, John, Christopher |
Improvements in or relating to contrast agents
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
DE69737915T2
(de)
|
1996-09-11 |
2008-03-13 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Verfahren zur diagnostischen Bilderzeugung der Nierenregion unter Verwendung eines Kontrastmittels und eines Vasodilators
|
US6331286B1
(en)
|
1998-12-21 |
2001-12-18 |
Photogen, Inc. |
Methods for high energy phototherapeutics
|
GB9624918D0
(en)
*
|
1996-11-29 |
1997-01-15 |
Nycomed Imaging As |
Particulate components
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6005083A
(en)
|
1997-03-28 |
1999-12-21 |
Neorx Corporation |
Bridged aromatic substituted amine ligands with donor atoms
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6392264B2
(en)
*
|
1997-07-08 |
2002-05-21 |
Hideki Takeuchi |
Semiconductor memory device and method of producing the same
|
US6001333A
(en)
*
|
1997-09-12 |
1999-12-14 |
See; Jackie R. |
Methods of preparing micro encapsulated agents for use in the detection of tumors by CT imaging
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US8974363B2
(en)
|
1997-12-11 |
2015-03-10 |
Provectus Pharmatech, Inc. |
Topical medicaments and methods for photodynamic treatment of disease
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
JP2002511312A
(ja)
*
|
1998-04-09 |
2002-04-16 |
ナイコムド イメージング エーエス |
生理学的パラメータを調べるための診断撮像における粒子状造影剤の使用
|
DE69914742T2
(de)
|
1998-05-29 |
2004-11-25 |
Skyepharma Canada Inc., Verdun |
Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
|
US8557298B2
(en)
|
1998-08-06 |
2013-10-15 |
Provectus Pharmatech, Inc. |
Medicaments for chemotherapeutic treatment of disease
|
US20040047804A1
(en)
*
|
1998-10-29 |
2004-03-11 |
The General Hospital Corporation, A Massachusetts Corporation |
Enhanced radiation therapy
|
ID29270A
(id)
|
1998-11-20 |
2001-08-16 |
Rtp Pharma Inc |
Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
|
US6203778B1
(en)
|
1998-12-08 |
2001-03-20 |
The Regents Of The University Of California |
Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
|
US7384623B1
(en)
|
1998-12-21 |
2008-06-10 |
Provectus Pharmatech, Inc. |
High energy phototherapeutic agents
|
US20020001567A1
(en)
*
|
1998-12-21 |
2002-01-03 |
Photogen, Inc. |
Intracorporeal medicaments for high energy phototherapeutic treatment of disease
|
US8470296B2
(en)
*
|
1998-12-21 |
2013-06-25 |
Provectus Pharmatech, Inc. |
Intracorporeal medicaments for high energy phototherapeutic treatment of disease
|
US6944493B2
(en)
*
|
1999-09-10 |
2005-09-13 |
Akora, Inc. |
Indocyanine green (ICG) compositions and related methods of use
|
US6351663B1
(en)
|
1999-09-10 |
2002-02-26 |
Akorn, Inc. |
Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
|
US6443976B1
(en)
|
1999-11-30 |
2002-09-03 |
Akorn, Inc. |
Methods for treating conditions and illnesses associated with abnormal vasculature
|
KR100866666B1
(ko)
|
2000-04-12 |
2008-11-04 |
지이 헬스케어 에이에스 |
펩티드 기재 화합물
|
EP1427393A2
(de)
*
|
2000-05-02 |
2004-06-16 |
Pharmacept GmbH |
Wirkstoffhaltige liposome
|
NO20004795D0
(no)
|
2000-09-26 |
2000-09-26 |
Nycomed Imaging As |
Peptidbaserte forbindelser
|
BRPI0210886B8
(pt)
|
2001-07-10 |
2021-05-25 |
Amersham Health As |
composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
|
EP1287833B1
(en)
*
|
2001-08-20 |
2007-10-10 |
FUJIFILM Corporation |
Liposome containing hydrophobic iodine compound and X-ray contrast medium comprising said liposome
|
DE10148065A1
(de)
*
|
2001-09-28 |
2003-04-17 |
Max Planck Gesellschaft |
(Ester)-Lysolecithine in Liposomen
|
EP1331012A1
(en)
|
2002-01-29 |
2003-07-30 |
BRACCO IMAGING S.p.A. |
Responsive paramagnetic MRI contrast agents
|
US20040022842A1
(en)
*
|
2002-06-03 |
2004-02-05 |
Mebiopharm Co., Ltd. |
Liposome preparations containing oxaliplatin
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
US8980310B2
(en)
*
|
2002-12-31 |
2015-03-17 |
Bharat Serums and Vaccines, Ltd. |
Non-pegylated long-circulating liposomes
|
JP2005170923A
(ja)
*
|
2003-10-21 |
2005-06-30 |
Konica Minolta Medical & Graphic Inc |
リポソーム含有x線造影剤およびその製造方法
|
CN1321697C
(zh)
*
|
2003-12-23 |
2007-06-20 |
中国人民解放军军事医学科学院毒物药物研究所 |
一种以磷脂类成分为成膜材料的超声造影剂组合物及其制备方法
|
US20050152842A1
(en)
*
|
2003-12-24 |
2005-07-14 |
Chun Li |
Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent
|
US7713517B2
(en)
*
|
2004-04-21 |
2010-05-11 |
Marval Biosciences, Inc. |
Compositions and methods for enhancing contrast in imaging
|
US8357351B2
(en)
|
2004-04-21 |
2013-01-22 |
Ananth Annapragada |
Nano-scale contrast agents and methods of use
|
WO2006009022A1
(ja)
*
|
2004-07-21 |
2006-01-26 |
Konica Minolta Medical & Graphic, Inc. |
リポソーム含有x線造影剤およびその製造方法
|
CN100574811C
(zh)
*
|
2005-01-10 |
2009-12-30 |
重庆海扶(Hifu)技术有限公司 |
一种高强度聚焦超声治疗用微粒类助剂及其应用
|
CN100427142C
(zh)
*
|
2005-01-10 |
2008-10-22 |
重庆海扶(Hifu)技术有限公司 |
一种高强度聚焦超声治疗用助剂及其筛选方法
|
CN100574809C
(zh)
*
|
2005-01-10 |
2009-12-30 |
重庆海扶(Hifu)技术有限公司 |
一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
|
US8703097B2
(en)
|
2005-02-11 |
2014-04-22 |
University Health Network |
Compositions and method for multimodal imaging
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
WO2006100692A2
(en)
*
|
2005-03-21 |
2006-09-28 |
Lifecare Innovations Pvt. Ltd. |
A novel inter and intra multilamellar vesicular composition.
|
WO2006107794A2
(en)
*
|
2005-04-01 |
2006-10-12 |
The Board Of Regents Of The University Of Texas System |
Poly(peptide) as a chelator: methods of manufacture and uses
|
NO20052429D0
(no)
*
|
2005-05-20 |
2005-05-20 |
Amersham Health As |
Konstrastmidler
|
NO20052428D0
(no)
*
|
2005-05-20 |
2005-05-20 |
Amersham Health As |
Kontrastmidler
|
TW200738752A
(en)
|
2006-01-31 |
2007-10-16 |
Bayer Schering Pharma Ag |
Modulation of MDL-1 activity for treatment of inflammatory disease
|
US7922999B2
(en)
|
2006-04-25 |
2011-04-12 |
The Regents Of The University Of California |
Administration of growth factors for the treatment of CNS disorders
|
US20070259031A1
(en)
*
|
2006-04-26 |
2007-11-08 |
The Regents Of The University Of California |
Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics
|
WO2007129311A2
(en)
*
|
2006-05-04 |
2007-11-15 |
Pan Sci Tech S.A. |
Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
|
WO2008109852A2
(en)
*
|
2007-03-07 |
2008-09-12 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of autoimmune conditions
|
KR100921959B1
(ko)
*
|
2007-06-04 |
2009-10-15 |
바이오스펙트럼 주식회사 |
다중층 리포좀 및 단일막 나노 리포좀을 포함하는다중-유화 베시클
|
EP2217146A4
(en)
|
2007-12-05 |
2015-10-14 |
Marval Biosciences Inc |
NANOMETRIC SCALE CONTRAST AGENTS AND METHODS OF USE
|
WO2009152445A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Marval Biosciences, Inc. |
Imaging of atherosclerotic plaques using liposomal imaging agents
|
US8591942B2
(en)
*
|
2009-09-23 |
2013-11-26 |
Indu JAVERI |
Methods for the preparation of liposomes comprising docetaxel
|
US20110070294A1
(en)
*
|
2009-09-23 |
2011-03-24 |
Javeri Indu |
Methods for the Administration of Drugs Using Liposomes
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
US10894098B2
(en)
|
2012-04-09 |
2021-01-19 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
US10525152B2
(en)
|
2009-10-09 |
2020-01-07 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
EP2694116B1
(en)
|
2011-04-06 |
2018-06-13 |
Board of Regents of the University of Texas System |
Lipid-based nanoparticles
|
WO2012136813A2
(en)
|
2011-04-07 |
2012-10-11 |
Universitetet I Oslo |
Agents for medical radar diagnosis
|
MX366972B
(es)
|
2012-01-20 |
2019-08-01 |
Ananth Annapragada |
Metodos y composiciones para caracterizar imagenes medicas en forma objetiva.
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
WO2013151650A1
(en)
*
|
2012-04-05 |
2013-10-10 |
University Of Florida Research Foundation, Inc. |
Neurophilic nanoparticles
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
JP6549554B2
(ja)
|
2013-03-15 |
2019-07-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
コレステロール流出を刺激する、減少した毒性を有するペプチド
|
EP3065771B1
(en)
|
2013-11-04 |
2019-03-20 |
UTI Limited Partnership |
Methods and compositions for sustained immunotherapy
|
US10258629B2
(en)
|
2014-03-28 |
2019-04-16 |
The Regents Of The University Of California |
Liposomal drug encapsulation
|
US9744251B2
(en)
|
2014-10-08 |
2017-08-29 |
Texas Children's Hospital |
MRI imaging of amyloid plaque using liposomes
|
MX2017008721A
(es)
|
2014-12-31 |
2017-11-17 |
Lantheus Medical Imaging Inc |
Composiciones de microesferas de gas encapsulado en lipidos y metodos relacionados.
|
SG10201913957PA
(en)
|
2015-05-06 |
2020-03-30 |
Uti Lp |
Nanoparticle compositions for sustained therapy
|
KR20180133527A
(ko)
|
2016-05-04 |
2018-12-14 |
랜티우스 메디컬 이메징, 인크. |
초음파 조영제의 제조 방법 및 장치
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
EP3412303A1
(en)
|
2017-06-08 |
2018-12-12 |
Medizinische Universität Innsbruck |
Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy
|
CN112138173A
(zh)
*
|
2020-10-26 |
2020-12-29 |
山东源科生物科技股份有限公司 |
一种胃肠超声造影剂及其制备方法
|
WO2023076220A1
(en)
*
|
2021-10-25 |
2023-05-04 |
Board Of Regents, The University Of Texas System |
Conjugates having antifouling nanoparticles and methods of use
|